Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Steroid Tapering in Bell's Palsy
NCT04406376Phase 4Unknown
- Sponsor
- Carmel Medical Center
- Start
- May 2020
- Primary completion
- May 2023
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
Phase 4, randomised, open-label trial of prednisone in Bell's palsy (2 arms), sponsored by Carmel Medical Center. Primary endpoint: House-Brackmann Facial Nerve Grading System at 90 days. Status: unknown.
02
Drugs
prednisone
03
Conditions
Bell's palsy
Beyond the preview
Go deeper on NCT04406376.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04406376.